Parmacology Word Scramble
|
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
| Question | Answer |
| Analgesia, euphoria, sedation | Agonist indications |
| Morphine effective against pain arising from the visceral, skeletal, and joints | Agonist indications |
| When morphine is added to volatile agents it increase the effects of anethesia | Agonist Indications |
| Morphine decrease cerebral blood flow in the absence of hypoventilation | Agonist clinical uses |
| Morphine reduces what during Myocardial infarctions | Preload also an Agonist clinical use |
| Demerol decrease what in post-op settings | Itching also a Agonist clinical use |
| Used independently to produce a limited level of analgesia | Agonist-Antagonist Indications |
| trhese drugs have the ability to produce Analgesia with limited risk of ventilation and physical dependence | Agonist-Antagonist |
| Partially reverses an agonist | Agonist-Antagonist |
| These drugs have a ceiling effect of analgesia | Agonist-Antagonist |
| Used to treat opiod respiratory depression | Antagonist Indications |
| Treat opiod induced respiratory depression do to maternal administration of opiods | Antagonist Indications |
| Treat deiliberate overdose | Antagonist Indications |
| Treat side effects of itching associated with neuraxial opiods | Antagonist Indications |
| 5X more potent than fentanyl, 1000x more potent morphine (strongest) | Sufentanil |
| Potency and lipid solubility Strongest to weakess | Sufentanyl> Remifentanyl> Alfentanyl> Morphine> Meperidine |
| Onset of action fastest to slow | Alfentanyl> Sufentanyl> Fentanyl> Morphine> Meperidine |
| Duration of action (longest to shortest) | Morhine> Meperidine> Fentanyl> sufentanyl> Alfentanyl> remifentanyl |
| Effect site equilibration | Fentanyl 6.4> Sufentanyl6.2> Alfentanl 1.4> Remifentanyl 1.1> Morphine 15-30 Meperidine |
| Partially reverse an agonist w/o completely reversing analgesic properties | Agonist-Antagonist Advantage |
| Limited risk of ventilator depression and physical dependency | Agonist-Antagonist Advantage |
| Insufficient analgesia properties for surgical anesthesia | Agonist-Antagonist Disadvantage |
| Ceiling effect | Agnist-Antagonist Disadvantage |
| One injection last for 48 hours | Clinical advantage of Morphine liposomal |
| no need for an indwelling catheter for continous infusion | Clinical advantage of Morphine liposomal |
| Designed for control of pain after major surgeries | Clinical advantage of Morphine liposomal |
| Not recommended for patients under 18 years old | Disadvantage of Morphine liposomal |
| Intrathecal admin has resulted in prolonged repsiratory depression | Disadvantage of Morhine liposomal |
| Most common side effect of neuraxial opiods | Pruritis |
| Most serious side effect of neuraxial opiods | Ventilation depression |
| Analgesia is dose dependent | Neuraxial Opiods |
| Neuraxial opiods __________ Mac for volatile anesthetics. | Decrease |
| Epidural admin of poorly lipid soluble opiods such as morphine will result in slower onset of action and longer duration of action. | Neuraxial Opiods |
| Sedation, CNS excitation, Neonatal Morbidity | Neuraxial Opiods |
| Main analgesia during labor & Delivery & after surgery | Meperidine |
| Effective in controlling post-op shivering | Meperidine |
| Meperidine is metaolized how? | in the liver |
| What's Meperidine primary route of elimination? | Urination excretion |
| Meperidine is metabolized into what | Normeperidine and Meperdinic acid |
| Common side effects of Morphine | Histamine release,nausea vomiting & pruritis |
| What is morphine's mechanism of action? | by acting on the mu receptors |
| What is Mu1 mechanism of action | produce analgesia and uphoria |
| What is Mu2 mechanism of action | responsible for hypoventilation, bradycardia, and physical dependency |
| How is Remifentanyl metabolized | only opiod not metabolized by liver, suscpetible to hydrolysis by plasma esteraase |
| What are advantages of remifentanyl | Quick onset, Short duration of action noncumulative effect |
| What are disadvantages of Remifentanyl | Cost, short duration of action could be disadvantage with long painful surgeries |
| Produced by anterior pituitary | growth hormone |
| produced by anterior pituitary | Prolactin |
| produced by anterior pituitary | Luteinizing hormone (gonadotropin) |
| produced by anterior pituitary | Adrenocorticotropic hormone (ATCH) |
| produced by anterior pituitary | thyroid stimulating hormone (TSH) |
| produced by posterior pituitary | ADH |
| produced by osterior pituitary | Oxytocin |
| How should patients with prior hypophysectomy be treated prior, during and after surgery? | Cortisol must be given continuously |
| How should patients scheduled for thyroidectomy be treated before ssurgery? | Thyroids have a long half life and may be omitted for a several days |
| What is the anti-inflammatory potency and Na retaining potency for Prednisolone? | Anti-inflammatory = 4 Na retaining potency .8 |
| What is the anti-inflammatory potency and Na retaining potency for Prednisone? | Anti-inflammtory = 4 Na retaining potency = .8 |
| WHat si the anti-inflammatory potency and Na retaining potency for Methylprednisone? | Anti-inflammatory = 5 Na retaining potency = 0.5 |
| What is the anti-inflammatory potency and Na retaining potency for Betamthasone? | Anti-inflammtory = 25 Na retaining potency = 0 |
| What is the anti-inflammatory potency and Na retainig potency for Dexamethasone? | Anti-inflammatory = 25 Na retaining potency = 0 |
| What is Fludricortisone | Anti-inflammmatory = 10Na retaining potency = 250 |
| What are the clinical uses of Oxytocin | causes uterine contractions |
| What are the clinical uses of ADH | Acts on the renal collecting ducts where it increases permeability of the cell to water; water is reabsorbed. |
| Suppression of HPA axis | warnings and adverse reaction of Corticosteroids |
| hypokalemisa is an advrse reaction of what | Corticsteroids |
| Metabolic acidosis is an adverse reaction of what | Corticosteroids |
| hyperglycemia is an adverse reaction of what | Corticosteroids |
| Developement of immune defiency may be caused by? | Corticsteriods |
| Inhibition of normal growth may be the effects of? | Corticosteroids |
| Peripheral blood changes may be caused by? | Corticosteroids |
| Osteoporosis and PUD are caused by? | Corticosteroids |
| Skeletal muscle myopathy is caused by | Corticosteroids |
| CNS dysfunction is caused by what? | Corticosteroids |
| What precautions should be taken with a patient who has chronic hypoadrenocorticism? | Dose of corticosteroid should be increased |
| Corticosteroid results in suppression of the ______ and leads to blunting normal release of | HPA axis and leads to blunting normal release of cortisol |
| How can you decrease the risk of patients having a CV collapse? | Increase the dosage of Corticosterods |
| What is SIADH (syndrome of inappropriate secretion of antiduretic hormone) | inappropriate and excessive secretion of ADH with subsequent water retension and dilutional hyponatremia. |
| What type of patients are prone to SIADH? | Head traumas, intracranial tumors, meningitis, pulmonary infections, & oat cell carcinomas |
| What antibiotic is used to treat SIADH | Demeclomycin (Declomycin) |
| What is the action of Demeclomycin | Promotes diuresis by antagonizing the effects of ADH on renal tubules. |
| What are the signs and synmptoms of SIADH? | Serum hypoosmality, HYPONATREMIA, most symptoms are associated with hyponatrmia |
| What factors speeds up induction from machine to alveoli? | anesthetic input, increased inspired partial pressure, increased ventilation, smaller the tube faster induction, increased FRC ratio |
| What speeds up inhaled anesthetics from alveoli to arterial blood? | low blood:gas partition coeffcient, low cardiac output, aveolar to venous partial pressure difference |
| What speeds up induction from arterial blood to brain? | Cerebral blood flow, arterial to venous pressure differnce, brain:blood partition coeffecient |
| Increasing the _______ in the inspired air will increase both the maximum tension that can be achieved in the alveoli and the rate increase in arterial tension. | anesthetic concentration |
| Increase ventilation, like PI, promotes input of inhaled anesthetics to offst ________ into blood | uptake |
| The net effect of increasing anesthetic concentration is a more rapid increase in PA and thus and increase in the ___________? | induction of anethesia |
| The greater the alveolar ventilation to FRC, the more _______ the increase in PA toward PI | rapid |
| What is the ratio of aveloalar ventilation to FCR ratio in neonates | 5:1 |
| What is the ratio of aveolar ventilation to FCR in adults | 1:5 |
| Indiction of anesthesia is slower with what? | more soluble anesthetic gases. |
| What drug characteristics may effect speed of induction of inhalational agents? | potency/solubility, oil:gas partition coeffceient. |
| What effect does a high oil:gas partician coeffecient have? | low MAC or higher potency |
| What effect does a low oil:gas partition coeffecient have? | High MAC or low potency |
| Define MAC | Minimal Alveolar Concentration is the concentration at 1 atm which causes immobility in 50% when expose to a noxious stimulus such as surgical stimulus |
| What patient characteristics increase MAC? | Hyperthermia, Hypernatremia, Hyperthyroid, chronic ETOH abuse, |
| What drugs increase MAC? | Cocaine, MAOI, Ephedrine, Levadopa |
| What patient characteristics decrease MAC? | Hypothermia, hyponatremia, elderly, acute alcohol ingestion, postpartum, BP<40 cardio-pulmonary bypass, anemia, metabolic acidosis hypoxia, pregnancy, |
| What drugs decrease MAC? | Benzos, clonidine, A2agonist, lithium, lidocaine, neuraxial oopiods, |
| what drugs decrease MAC? | Ketamine, Chlorpromazine, Physostigmine, Pancurium, Verapamil, Tetrahydrocanbinol hydroxine |
| All inhalational agents are excreted where | Lungs |
| Nitrous Oxide is metablized where and how much? | Gi tract and .004% |
| Deslflurane is metabolized by what and how much | .02% from P450 |
| Isoflurane is metabolized how and how much | 2% from P450 |
| Sevoflurane is metabolized how and how much | 5% FROM P450 |
| How does volatile anesthetics arterial to venous pressure difference will effect the duration of actions? | The higher the solubility the more the agent will diffuse into the muscles or blood, thus prolonging induction. |
| In regards to volatile anesthetics which is the most soluble agent in use? | Isoflurane |
| What inhalational agent has the greatest analgesia and paralytic properties? | Nitrous Oxide |
| What is compound A? | Degredation product Sevoflurane and CO2 absorbers. |
| What risks are associated with Compound A | Neprotoxicity |
| What can be done to prevent formation of Compound A | Administer at least 2L of fresh gas flow to minimize formation of compound A |
| What is diffusion hypoxemia? | When Nitrous Oxide is discont it leads to a reversal of partial pressure gradients, N2O leaves the blood and entrs the alveoli and dilutes PAO2 and PCO2 in the alveoli |
| What can be done to avoid diffusion hypoxia? | Hyperventilate the patient with 100% O2 1-5 mins after turning off NO2. |
| What is the MAC, blood:gas partition coeffecient of NITROUS OXIDE? | Mac = 105 Blood:gas PC = 0.46 oil:gas PC = 1.4no vapor pressure |
| What is the MAC, VP, b:g partition coeffecient of ISOFLURANE | MAC = 1.2 B:G = 1.46 oil:gas = 98 VP = 240 |
| What is the MAC, VP, B:G O:G partition coeffecient of SEVOFLURANE | MAC = 2 B:G = 0.69, O:G = 55 VP = 160 |
| What is the MAC, VP, B:G, O:G partition coeffecient of DESFLURANE | MAC = 6 B:G = 0.42 O:G = 18.7 VP = 681 |
| What are the advantages of Isoflurane | safer for kidneys, does not cause seizures, decrease ICP, decrease CMRO2 requirements, decrease BP but not CO, |
| What are the disadvantages of Isoflurane | Profound ventilation depression, tachepnia, Increased heart rate. |
| What are the disadvantages of Desflurane? | very pungent, airway irritant, increased coughing, increased incidence of laryngospasm, requires special heated vaporizer, decrease CO and BP, decrease cereberal blood flow |
| What are the advantages of Deflurane? | very little metabolism, unlikely to form neoantigens, |
| What are the advantages of Sevoflurane? | has no preservatives, but less stable, Reasonble MAC, non-irritating to airways, does not change heart rate. |
| What are the disadvantages of Sevoflurane? | less stable, breaks down in presence of soda lime, nephrotoxic, produces compounds A-F |
| What are the disadvantages of NO2? | either no effect or modest incerease in BP, does not increase CO2, provides analgesia, fast revrsible, weak trigger of MH |
| What are the disadvantages of Nitrous Oxide? | doe not relax skeletal muscles, cause diffusion hypoxia, depress vent response, can increase volume or pressure of air in gut, middle ear, lungs and head |
| What are s&s of fluoride toxicity? | Polyuria, hyernatremia, hyperosmolarity, increased serum creatinine, inability to concentrate urine. |
| What agent is fluortoxcity associated with? | Methoxyflurane |
| Inorganic fluoride metabolite is _________? | nephrotixic |
| Currently used anesthetics have significantly less metabolism and are less soluble thus | decreasing the nephrotoxic effects |
| What triggers MH | Succinylchloine and volatile anesthetics |
| True or false; all volatiel anesthetics can trigger MH | true |
| What is the most potent trigger of MH | Halothane although it is no longer used in the states. |
| What is the weakest volatile aneshtetic that can trigger MH? | Nitrous Oxide |
Created by:
boharris6928
Popular Nursing sets